These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18302883)

  • 1. [Polymorphisms of FAS and FASL genes and susceptibility of silicosis].
    Wu F; Qu YB; Sun P; Ji F; Qiu YL; Miao WB; Wang W; Jin RF; Xia ZL
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Jan; 26(1):7-11. PubMed ID: 18302883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms of IL-1A, IL-1B, IL-1RN, NFKB1, FAS, and FASL, and risk of silicosis in a Chinese occupational population.
    Wu F; Xia Z; Qu Y; Tang Y; Cao D; Sun P; Christiani DC
    Am J Ind Med; 2008 Nov; 51(11):843-51. PubMed ID: 18666137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in the apoptosis-associated genes FAS and FASL and risk of oral cancer and malignant potential of oral premalignant lesions in a Taiwanese population.
    Wang LH; Ting SC; Chen CH; Tsai CC; Lung O; Liu TC; Lee CW; Wang YY; Tsai CL; Lin YC
    J Oral Pathol Med; 2010 Feb; 39(2):155-61. PubMed ID: 20359312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic polymorphisms of apoptosis-associated genes FAS and FASL and risk of colorectal cancer].
    Yang S; Miao XP; Zhang XM; Sun T; Qu SN; Xiong P; Ye YJ; Guo YL; Tan W; Wang S; Lin DX
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2132-5. PubMed ID: 16313826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility to oral cancers with CD95 and CD95L promoter SNPs may vary with the site and gender.
    Daripally S; Nallapalle SR; Katta S; Prasad VV
    Tumour Biol; 2015 Sep; 36(10):7817-30. PubMed ID: 25944167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of death pathway genes FAS and FASL and risk of nasopharyngeal carcinoma.
    Cao Y; Miao XP; Huang MY; Deng L; Lin DX; Zeng YX; Shao JY
    Mol Carcinog; 2010 Nov; 49(11):944-50. PubMed ID: 20842669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between FAS/FASL gene polymorphisms and susceptibility of coal worker's pneumoconiosis].
    Ni CH; Song ZF; Jia XM; Li AP; Li CP; Li SK; Li YM; Wang ZL; Zhou Y; Wang SY; Zhang ZD; Zhou JW
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2007 Sep; 25(9):532-6. PubMed ID: 17997887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of death pathway genes FAS and FASL polymorphisms in chronic HBV infection.
    Zamani AG; Barlas IO; Durakbasi-Dursun G; Ural O; Erdal E; Yildirim MS
    Int J Immunogenet; 2013 Dec; 40(6):482-7. PubMed ID: 23560484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer.
    Zhang X; Miao X; Sun T; Tan W; Qu S; Xiong P; Zhou Y; Lin D
    J Med Genet; 2005 Jun; 42(6):479-84. PubMed ID: 15937082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in promoter region of FAS and FASL gene and risk of cardia gastric adenocarcinoma.
    Zhou RM; Wang N; Chen ZF; Duan YN; Sun DL; Li Y
    J Gastroenterol Hepatol; 2010 Mar; 25(3):555-61. PubMed ID: 20074157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fas/FasL promoter gene polymorphism in patients with rheumatoid arthritis.
    Kobak Ş; Berdeli A
    Reumatismo; 2012 Dec; 64(6):374-9. PubMed ID: 23285481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
    Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S
    Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of promoter polymorphisms of Fas -FasL genes with development of Chronic Myeloid Leukemia.
    Edathara PM; Gorre M; Kagita S; Vuree S; Cingeetham A; Nanchari SR; Meka PB; Annamaneni S; Digumarthi RR; Satti V
    Tumour Biol; 2016 Apr; 37(4):5475-84. PubMed ID: 26563376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional polymorphisms in FAS/FASL system increase the risk of neuroblastoma in Chinese population.
    Han W; Zhou Y; Zhong R; Wu C; Song R; Liu L; Zou L; Qiao Y; Zhai K; Chang J; Huang L; Liu L; Lu X; Lou J; Yu D; Tan W; Zhang J; Wang H; Miao X
    PLoS One; 2013; 8(8):e71656. PubMed ID: 23951214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional genetic variants in apoptosis-associated FAS and FASL genes and risk of bladder cancer in a Turkish population.
    Verim L; Timirci-Kahraman O; Akbulut H; Akbas A; Ozturk T; Turan S; Yaylim I; Ergen A; Ozturk O; Isbir T
    In Vivo; 2014; 28(3):397-402. PubMed ID: 24815844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of FAS-1377, FAS-670, and FASL-844 polymorphisms in tumor onset, progression, and pigment phenotypes of Swedish patients with melanoma: a case-control analysis.
    Zhang H; Sun XF; Synnerstad I; Rosdahl I
    Cancer J; 2007; 13(4):233-7. PubMed ID: 17762757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esophageal cancer.
    Jain M; Kumar S; Lal P; Tiwari A; Ghoshal UC; Mittal B
    Cancer Detect Prev; 2007; 31(3):225-32. PubMed ID: 17561354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between polymorphism of interleukin-8 and silicosis susceptibility].
    Sun D; Fan XY; Wang LQ; Li CL
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2011 Jul; 29(7):522-4. PubMed ID: 22214159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms in alveolar macrophage response-related genes, and risk of silicosis and pulmonary tuberculosis in Chinese iron miners.
    Qu Y; Tang Y; Cao D; Wu F; Liu J; Lu G; Zhang Z; Xia Z
    Int J Hyg Environ Health; 2007 Dec; 210(6):679-689. PubMed ID: 17223386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FASL polymorphism is associated with response to bacillus Calmette-Guérin immunotherapy in bladder cancer.
    Lima L; Ferreira JA; Tavares A; Oliveira D; Morais A; Videira PA; Medeiros R; Santos L
    Urol Oncol; 2014 Jan; 32(1):44.e1-7. PubMed ID: 23948181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.